Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 3/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 2/20 | 0.30 |
| ▸ | CDC25A | P30304 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | G6PD | P11413 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13096352 | 1.00 | PTGS1 (0.33) | PTGS1PTGS2MGLLFAAHCES1 | |
| SCHEMBL16307242 | 0.98 | PTGS1 (0.32) | PTGS1PTGS2MGLLFAAH | |
| SCHEMBL16307269 | 0.86 | — | — | |
| SCHEMBL16307265 | 0.84 | PTGS1 (0.32) | PTGS1PTGS2MGLLFAAHCES1 | |
| SCHEMBL17528652 | 0.84 | PTGS1 (0.32) | PTGS1PTGS2MGLLFAAHCES1 | |
| SCHEMBL16307286 | 0.84 | HSF1 (0.33) | PTGS1PTGS2MGLLFAAHCES1 | |
| SCHEMBL16307263 | 0.84 | PTGS1 (0.32) | PTGS1PTGS2MGLLFAAHCES1 | |
| SCHEMBL17188374 | 0.83 | PTGS1 (0.30) | PTGS1PTGS2MGLLFAAH | |
| SCHEMBL17188378 | 0.83 | — | — | |
| SCHEMBL19758028 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8927971-B2 | Semiconducting compounds and devices incorporating same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2015-01-06 | — | — | US | disclosed |
| US-20100252112-A1 | Semiconducting Compounds and Devices Incorporating Same | POLYERA CORPORATION | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100252112-A1 | Semiconducting Compounds and Devices Incorporating Same | HTT, SUV39H1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | PTGS1 3764/4885PTGS2 3456/4885MGLL 1961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.